A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
about
Cognitive-behavioral therapy for adolescent depression and suicidalityPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsNewer generation antidepressants for depressive disorders in children and adolescentsNeurobiology of adolescent substance use and addictive behaviors: treatment implicationsTreatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed ModelBone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetineOpioid Use Disorders.Pharmacological strategies for detoxification.Treatment of Adolescent Substance Use DisordersSequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders.Screening and brief intervention for underage drinkers.Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.Substance use and the treatment of resistant depression in adolescents.Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders.Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.How adolescents with substance use disorder spend research payments.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services researchTREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.Evidence base on outpatient behavioral treatments for adolescent substance use: updates and recommendations 2007-2013.The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.Access to treatment for adolescents with substance use and co-occurring disorders: challenges and opportunities.Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescentsDifferences in Characteristics and Treatment Received among Depressed Adolescent Psychiatric Outpatients with and without Co-Occuring Alcohol Misuse: A 1-Year Follow-Up StudyPsychotropic medications and substances of abuse interactions in youth.Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practiceMajor depression and treatment response in adolescents with ADHD and substance use disorder.Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders.Reduced substance use as a secondary benefit of an indicated cognitive-behavioral adolescent depression prevention program.The comparative effectiveness of outpatient treatment for adolescent substance abuse: a meta-analysis.The Impact of Motivational Interviewing on Delinquent Behaviors in Incarcerated Adolescents.Integrating substance use treatment into adolescent health careEmergency department detection of adolescents with a history of alcohol abuse and alcohol problemsThe short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trialCombined cognitive-behavioural therapy and pharmacotherapy for adolescent depression: Does it improve outcomes compared with monotherapy?Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorderTreatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations
P2860
Q22252299-518CDBEB-371A-4D0F-B82E-F7B0799CCC52Q24187748-833679D3-EEAC-42D3-937F-903AB76C2B8CQ24202831-D49358DE-E528-47C3-881E-98264E2674FDQ24202873-E9867FD2-B1D8-49A0-BD1E-0810B66158BDQ26852735-9D6939A6-2F50-414D-AB02-D51A85973F6DQ26866733-E34226A0-DC62-4647-90D6-B6DE16DB740DQ28384165-98662669-56BF-436C-A0EA-38DA270880B4Q30249393-89DE4CD4-CBA5-481E-AC14-30CDC3B06597Q33582092-16BE109B-ED7E-4400-B416-611F52DB5A0EQ33621337-2243BB27-C5B4-4C00-9CAE-4DD6A6E4BA27Q33684304-1599B2D9-30CE-4A0C-8823-15A8BD4EB15EQ33765079-C1049F77-46CD-437E-93CA-EB20FD025F8BQ33876388-5B0D1673-8D39-4B84-B7AF-21A94533252DQ33956890-5C97453E-4082-488A-8AF3-B4887643A15BQ34081359-0CAB53C9-6B5B-4F77-9232-590103D8531DQ34158675-420AFFD0-EAA1-41A6-B8CA-2A3A478C91FAQ34176823-0F7DE392-EFF9-4345-88D2-C38BE5D4C223Q34277168-26C8AEDF-772D-4FF9-8B90-5F0051DDC478Q34339932-10830A02-93BF-4934-A9CF-04BD4B298B82Q34357284-9857EE58-566F-49E3-BEAE-728026217E3EQ34372579-CD332AFE-A541-4A2F-A551-4C2DA41FCFE3Q34424651-886B60CB-D206-4AAE-9602-EF9B28A610EAQ34504812-C69C35E7-2B62-470D-93BB-FECCD7BEBB8BQ34606514-08AD3159-E015-4173-B226-E14ED281A11CQ34981271-C7570558-9293-4E55-A9F3-6944B3AA8321Q35071077-03CC8B26-502C-46EC-99BD-C513FE6ACF22Q35132873-0C684D39-F37B-4DFC-A565-995B807D9A17Q35158688-1A6EC0A8-24E0-4F8E-9EE1-DA32F54544D5Q35633131-5EBCB2E4-F3AD-4DEE-94AB-A9CD10DCFDF5Q36151947-2ACBC912-C523-4B39-93AF-557343B067E5Q36278345-0B6B8352-B86B-481F-98E9-0D7CCB86F494Q36335864-FA870431-86D4-408C-B194-9C8F77E08EDEQ36730971-5939DB67-552E-4B76-B060-32C2E96F9313Q36802860-D6E84B6D-41AA-4591-8FA1-281E38F3884CQ36949328-71CFBFFC-3292-4700-9292-965FDD151521Q37152939-5C94B929-C411-451C-8A6F-BB4809E94DD6Q37165235-488B18B6-12AA-4C9F-B6A4-F3CF2BB10E6DQ37200944-DE9369E3-E738-40AE-9274-0923E84C4057Q37288084-74E925D8-6C7A-4A71-B2FD-8B8D9312A75CQ37292488-5EBD6B33-A055-4207-9FEF-9C2B1E217F62
P2860
A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A randomized controlled trial ...... , and substance use disorders.
@en
A randomized controlled trial ...... , and substance use disorders.
@nl
type
label
A randomized controlled trial ...... , and substance use disorders.
@en
A randomized controlled trial ...... , and substance use disorders.
@nl
prefLabel
A randomized controlled trial ...... , and substance use disorders.
@en
A randomized controlled trial ...... , and substance use disorders.
@nl
P2093
P1433
P1476
A randomized controlled trial ...... , and substance use disorders.
@en
P2093
Constance Klein
Michelle Lohman
Paula D Riggs
Robert D Davies
Shannon K Stover
Susan K Mikulich-Gilbertson
P304
P356
10.1001/ARCHPEDI.161.11.1026
P407
P577
2007-11-01T00:00:00Z